Oppenheimer 26 th Annual Healthcare Conference Bill Rutherford

Oppenheimer 26 th Annual Healthcare Conference Bill Rutherford Chief Financial Officer and Executive Vice President Vic Campbell Senior Vice President Mark Kimbrough Vice President, Investor Relations

FORWARD-LOOKING STATEMENTS AND NON-GAAP FINANCIAL MEASURES This presentation may contain certain forward-looking statements provided by Company management. These statements are intended to be covered by the safe-harbor provisions of the Private Securities Litigation Reform Act of 1995. Forward-looking statements include all statements that do not relate solely to historical or current facts, including statements regarding future operations, financial results, cash flows, costs and cost management initiatives, capital structure management, growth rates, and operational and strategic initiatives, and can also be identified by the use of words like “may, ” “believe, ” “will, ” “expect, ” “project, ” “estimate, ” “anticipate, ” “intend, ” “plan, ” “initiative, ” “continue” or words or phrases of similar meaning. These forward-looking statements speak only as of the date hereof and are based on our current plans and expectations and are subject to a number of known and unknown uncertainties and risks, many of which are beyond our control. These risks and uncertainties are described in headings such as “Risk Factors” in our annual report on Form 10 -K for the year ended December 31, 2014 and other reports filed with the Securities and Exchange Commission. As a consequence, current plans, anticipated actions and future financial position and results of operations may differ significantly from those expressed in any forward-looking statements in today’s presentation. You are cautioned not to unduly rely on such forward-looking statements when evaluating the information presented and we do not intend to update any of these forward-looking statements. The presentation may contain certain non-GAAP measures, including Adjusted EBITDA. The Company’s earnings releases for the year ended December 31, 2014, and for the quarter and nine months ended September 30, 2015, located on the Company’s investor relations page at www. hcahealthcare. com, include reconciliations of certain non-GAAP financial measures and the most directly comparable financial measures calculated in accordance with GAAP. These non-GAAP financial measures should not be considered alternatives to the GAAP financial measures. References to “Company” used herein refer to HCA Holdings, Inc. and its affiliates, unless otherwise stated or indicated by context. 1 1

HCA has a diversified portfolio of assets strategically selected in attractive markets…… HCA’s top ten markets generate approximately 63% of Adjusted EBITDA Anchorage Western Idaho New Hampshire Idaho Falls Salt Lake City Denver Las Vegas Wichita Kansas City Chattanooga Augusta NWGA Atlanta Middle GA El Paso Central Louisiana Lafayette San Antonio New Orleans Corpus Christi Mc. Allen Richmond Nashville Dallas / Fort Worth Austin S-VA Frankfort Oklahoma City Southern California N-VA Terre Haute San Jose Central London Houston Tallahassee Panhandle Tampa Myrtle Beach Trident / Charleston Jacksonville North Central Florida Orlando Treasure Coast Miami/Fort Lauderdale/WPB Brownsville Gold labels indicate top 10 domestic markets by 3 Q 2015 Adjusted EBITDA. 2

Dallas Market 10 1 1 Hospital ~3, 000 ~7, 000 5 12 31 6 3 Acute Hospitals Children’s Hospital Behavioral Health Beds (Occupancy 71%) Physicians on Med Staff Trauma Centers Surgery Centers Urgent Care Centers Free Standing ERs 3

HCA’s Sustainable Growth Agenda Industry leading quality and service Profitable growth through distinctive MD and patient relationships and value Efficiency levels that continue to lead the industry A well-informed response to evolving market environment Unparalleled development of future leaders “Be the Preferred Provider System in the Market” 4

HCA Continues to Leverage Its Financial Strength (YTD 9/30/15 compared to prior year) 5. 2% Equivalent Admissions(1) 1. 4% Revenue per Equivalent Admission(1) 7. 9% Revenues 5. 7% Adjusted EBITDA 9. 5% Adjusted Net Income Attributable to HCA Holdings, Inc. (2) 15. 1% Adjusted Diluted Earnings Per Share(2) 5 (1) (2) Same facility Net income attributable to HCA Holdings, Inc. and diluted earning per share exclude losses (gains) on sales of facilities, losses on debt retirement, and legal claim costs. 5

What Differentiates HCA Local Market Strategy & Execution Clinical Excellence Capital Deployment Size and Scale Market Diversification Culture and Values 6

Oppenheimer 26 th Annual Healthcare Conference Bill Rutherford Chief Financial Officer and Executive Vice President Vic Campbell Senior Vice President Mark Kimbrough Vice President, Investor Relations